Piramal Pharma Q2 FY27 Results: Consolidated Net Profit ₹5.03 Crore on Total Income of ₹2,653 Crore
Piramal Pharma (NSE: PPLPHARMA) reported consolidated total income of ₹2,652.99 crore and a net profit of ₹5.03 crore for the quarter ended 30 Sep 2026. On a standalone basis, total income was ₹1,483.31 crore and net profit was ₹170.74 crore. The company said in a filing on 27 Oct 2026.
- Earnings
- pharmaceutical CDMO